Katrin Straßburger-Krogias

Siponimod versus placebo in secondary progressive multiple sclerosis (EXPAND): a double-blind, randomised, phase 3 study

Ludwig Kappos, Amit Bar‐Or, Bruce Cree et al. · The Lancet · 2018 · 896 citations

Neurological Disorder, Clinical Neurology, Clinical Trials +9

Fumarate treatment in progressive forms of multiple sclerosis: first results of a single-center observational study

Katrin Straßburger-Krogias, Gisa Ellrichmann, Christos Krogias et al. · Therapeutic Advances in Neurological Disorders · 2014 · 34 citations · Full text

Breakthrough treatment with bortezomib for a patient with anti-NMDAR encephalitis

Christoph Schroeder, Claude Back, Ümmügülsüm Koc et al. · Clinical Neurology and Neurosurgery · 2018 · 32 citations

Neurobiology Of Disease, Medicine, Neurovirology +7

Hypoechogenicity of brainstem raphe nuclei is associated with increased attack frequency in episodic migraine

Ilya Ayzenberg, Ilias Nastos, Katrin Straßburger-Krogias et al. · Cephalalgia · 2015 · 24 citations · Full text

Glial Cells Express Nuclear Nrf2 After Fumarate Treatment for Multiple Sclerosis and Psoriasis

Imke Metz, Sarah Traffehn, Katrin Straßburger-Krogias et al. · Neurology Neuroimmunology & Neuroinflammation · 2015 · 20 citations · Full text

Immunology, Immune Regulation, Cell Death +24